ALTS: JanOne Inc. Stock

by  •  • Comments Off on ALTS: JanOne Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 74.29
Enterprise Value ($M) 97.18
Book Value ($M) 24.08
Book Value / Share 1.71
Price / Book 3.08
NCAV ($M) -18.91
NCAV / Share -1.34
Price / NCAV -3.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -1.09
Return on Equity (ROE) -1.80

Liquidity (mrq)
Quick Ratio 0.75
Current Ratio 0.75

Balance Sheet (mrq) ($M)
Current Assets 31.90
Assets 74.89
Liabilities 50.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 33,012 133,892 24.66
2025-03-06 31,277 118,854 26.32
2025-03-05 38,359 134,883 28.44
2025-03-04 25,952 160,363 16.18

(click for more detail)

Similar Companies
ALBT – Avalon GloboCare Corp. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc. ALVR – AlloVir, Inc.
ALZN – Alzamend Neuro, Inc.


Financial data and stock pages provided by
Fintel.io